LongCovid
“If you are high-risk, the answer is straightforward. If you are low-risk, there is less consensus. Based on all of the recent findings, there is consensus that if…
“The pandemic has not ended. It is evolving, with big implications. Here are six. Do not miss this excellent analysis article written by Andrew Nikiforuk in The Tyee.…
“In this study, COVID-19 was a leading cause of death among individuals aged 0 to 19 years in the US. Our findings underscore the public health relevance of…
A very interesting and powerful testimony of a 28-year old law student from Canada suffering Long COVID since March 2020. This article, where Sophie Harrison shares her experience with Long…
During the fourteenth meeting of the International Health Regulations (2005) (IHR) Emergency Committee regarding the coronavirus 2019 disease (COVID19) pandemic (Friday 27 January 2023, 14:00 to 17:00 CET),…
Scientists are starting to detect clots in long COVID patients’ smallest blood vessels—which might help explain the condition’s debilitating symptoms. In 2021, physiologist Etheresia Pretorius at the Stellenbosch…
EuCARE answers to an emergency call from the European Union, in the frame of the Horizon Europe programme, to confront the COVID-19 epidemics and in particular the newly emerging…
“With nearly 20 percent of U.S. adults who have had COVID-19 experiencing symptoms, here are the current theories on who is most at risk, how long COVID develops,…
On 5 January 2023, the EU-funded projects COVIRNA, ENVISION and COVend held a joint webinar on ’Addressing unmet clinical needs, practices and patient outcomes: the impact of EU-funded projects‘. Experts presented…
“Humoral autoimmunity may contribute to cognitive impairment in post-COVID-19 syndrome”. The majority of Long COVID patients with cognitive impairment may have CNS autoantibodies as reported in a study led by Charité…